Sundy, John S <br/><br/>
Reduction of plasma urate levels following treatment with multiple doses of pegloticase (polyethylene glycol-conjugated uricase) in patients with treatment-failure gout: results of a phase II randomized study.  [electronic resource] 

 -  Arthritis and rheumatism  Sep 2008 
 - 2882-91 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1529-0131 
<br/><br/><label>Standard No.: </label>10.1002/art.23810  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Female<br/>Gout--drug therapy<br/>Humans<br/>Intention to Treat Analysis<br/>Male<br/>Middle Aged<br/>Patient Selection<br/>Polyethylene Glycols--administration & dosage<br/>Treatment Outcome<br/>Urate Oxidase--administration & dosage<br/>Uric Acid--blood